Clinical trial · Interventional
Comparing Two Modes of Survivorship Care
Comparing Two Modes of Survivorship Care: A Randomized Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The main purpose of this study is to research the comparative effectiveness of two potential models of health care to deliver preventive services and chronic care management to the growing population of adult and pediatric survivors of childhood cancer. The central hypothesis is that survivorship care delivered by a subject's primary care doctor after the subject is empowered with individualized follow-up recommendations prepared by a cancer survivor specialist is similar to care provided in a specialty survival clinic.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Childhood Cancer | Childhood Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| empowered primary care model | Other | — | UNRESOLVED |
| specialty survivor clinic | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- empowered primary care model
- description
- patients receive an individualized "prescription" for survivorship care prepared by a cancer survivor specialist to be implemented by the primary care doctor
- interventionNames
- Other: empowered primary care model
- type
- EXPERIMENTAL
- label
- specialty survivor clinic
- description
- patient attends a specialty survivor clinic at Yale for survivorship care
- interventionNames
- Other: specialty survivor clinic
Primary outcomes (2)
- measure
- adherence to guideline-recommended surveillance (medical record abstraction)
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Year
- Maximum age
- 29 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosis of any malignancy at age \<18 years and reported to Yale-New Haven Hospital or Connecticut Children's Medical Center (CCMC) tumor registry * Currently alive and cancer-free * Primary residence within approximately 100 miles of Yale-New Haven Hospital or CCMC * ≥ 1 year status post completion of all cancer-related therapy * Elapsed time of less than 12.0 years since diagnosis of malignancy * Speaking and writing knowledge of English. For subjects \<18 years, at least one parent must satisfy this requirement. * No previous attendance at the Yale HEROS or CCMC Reach for the STARS survivorship clinics, or other specialty survivorship clinic Exclusion Criteria: * n/a
References
Publications (0)
Data not yet available